Accelerating China, Covidien Establishes JV With Changzhou Kangdi
This article was originally published in PharmAsia News
Executive Summary
Irish device maker Covidien has set up a joint venture with Changzhou Kangdi to capture the value segment in China’s vast lower-tier market.
You may also be interested in...
Covidien Taps Local Players In China, Brazil To Reach Public Hospital Markets
Covidien acquired a privately held manufacturer of electrosurgical generators based in Ribeirao Preto, Brazil, and established a joint venture with a manufacturer of open stapler products based in Kiangsu Province in China, to access patients who can’t afford top-tier hospitals in those countries.
Brazilian Presidential Decree Opens Door To Less Stringent GMP Certification Requirements For Foreign Firms
New decree opens door to more lenient good manufacturing practice certification requirements than are currently imposed on international medical device manufacturers seeking to gain market entry in Brazil.
Medtechs Must Reflect On China Localization Policies As VBP Expands
China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.